Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CMS Expects Part D Rebates Will Continue Despite Donut Hole Discounts, Guidance Says

This article was originally published in The Pink Sheet Daily

Executive Summary

CMS addresses stakeholder concerns in final guidance on Part D donut hole discount program.

You may also be interested in...



Part D Coverage Gap Discounts Not Linked To Price Increases In 2011 – GAO

GAO found the prices for high-expenditure brand-name drugs used by beneficiaries in the Medicare Part D coverage gap and by those who did not reach the gap in 2011 increased at a similar rate before and after the discount program was implemented in January 2011.

Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011

Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS070663

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel